No. | Tumor ID | Age/gender | Race/ethnicity | Tumorigenicity at passage I | Passages in vivo |
---|---|---|---|---|---|
1 | K012 | 43/F | AA | 3/4 | 5 |
2 | K014 | 70/M | W | 6/7 | 4 |
3 | K023 | 36/M | AA | 4/5 | 5 |
4 | K024 | 59/M | W | 10/10 | 4 |
5 | K031 | 70/M | W | 3/7 | 2 |
6 | K033 | 66/M | H | 5/8 | 3 |
8 | K035 | 70/M | W | 8/9 | 5 |
9 | K038 | 64/M | AA | 4/5 | 4 |
10 | K045 | 60/M | W | 6/7 | 3 |
11 | K053 | 72/MÂ | W | 1/5 | 3 |
12 | K060 | 56/FÂ | W | 7/10 | 3 |
13 | K064 | 58/F | W | 9/9 | 4 |
14 | A0313 | * | * | 2/4 | 5 |
15 | A46 | 65/F | A | 5/5 | 5 |
16 | A128 | 83/MÂ | * | 3/8 | 2 |
17 | A129 | 70/MÂ | * | 4/7 | 2 |
18 | V0914 | 50/MÂ | * | 8/10 | 5 |
19 | K019 | 58/M | W | 0/5 | – |
20 | K025 | 45/M | H | 0/5 | – |
21 | K032 | 80/M | W | 0/5 | – |
22 | K046 | 64/F | W | 0/5 | – |
23 | K054 | 75/F | H | 0/10 | – |